ZBH Company Profile and Key Details

Q: Who are the executives of ZBH?

Dr. Nitin Goyal M.D.Chief Science, Technology & Innovation OfficerMr. Sang YiPres of Asia PacificMr. Bryan C. HansonChairman, Pres & Chief Executive OfficerMr. Suketu P. UpadhyayExecutive Vice President & Chief Financial OfficerMr. Chad F. PhippsSenior Vice President, Gen. Counsel & Sec.Mr. Paul A. StellatoVice President, Controller & Chief Accounting OfficerMr. Wilfred van ZuilenPres of Europe, Middle East & AfricaMs. Angela MainSenior Vice President, Global Chief Compliance Officer & Associate Gen. Counsel of Asia PacificMr. Ivan TornosChief Operating OfficerMs. Keri P. MattoxSVice President and Chief Communications & Admin. OfficerMr. Zeeshan TariqSenior Vice President & Chief Information Officer

NYSE : ZBH

Zimmer Biomet

$92.44

-2.165-2.29%

At Close 4:00 PM

61.39

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Zimmer Biomet Holdings, Inc. (ZBH) stock declined over -2.29%, trading at $92.44 on NYSE, down from the previous close of $94.61. The stock opened at $93.12, fluctuating between $91.45 and $93.73 in the recent session.

Stock Snapshot

94.605

Prev. Close

17.88B

Market Cap

91.45

Day Low

10.9

P/E Ratio

8.48

EPS (TTM)

5.39

Cash Flow per Share

93.12

Open

193.46M

Number of Shares

93.725

Day High

99.74%

Free Float in %

59.83

Book Value

1.36M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	94.04	94.05	91.45	92.44	1.36M
Sep 09, 2026	93.02	95.73	92.55	94.61	1.99M
Sep 08, 2026	97.05	97.23	91.87	94.22	3.13M
Sep 04, 2026	97.77	98.77	96.84	98.07	1.32M
Sep 03, 2026	100.06	101.81	98.15	98.92	1.25M
Sep 02, 2026	99.32	101.71	99.01	99.50	1.39M
Sep 01, 2026	101.49	102.86	99.04	99.40	1.32M
Aug 31, 2026	100.20	100.30	99.53	100.04	1.29M
Aug 28, 2026	99.61	101.32	99.25	100.91	1.05M
Aug 27, 2026	99.93	101.28	99.21	99.48	1.35M
Aug 26, 2026	99.52	101.98	99.20	101.38	1.35M
Aug 25, 2026	100.14	100.87	99.28	100.24	1.27M
Aug 24, 2026	101.32	102.12	100.69	100.98	1.5M
Aug 21, 2026	98.67	101.15	98.67	100.98	1.16M
Aug 20, 2026	100.01	101.63	98.97	98.97	1.31M
Aug 19, 2026	98.72	101.95	98.09	100.74	1.5M
Aug 18, 2026	99.58	100.38	98.27	99.15	1.21M
Aug 17, 2026	99.78	100.15	97.87	98.20	1.75M
Aug 14, 2026	99.59	101.16	98.97	100.65	2.15M
Aug 13, 2026	98.42	100.06	97.62	99.57	2.62M

Contact Details

Warsaw, IN 46580

United States

https://www.zimmerbiomet.com 574 267 6131

About Company

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Stock Peers

BIO

-8.22-2.18%

Bio-Rad Laboratories, Inc.$368.75 BIO-B

21.98+6.02%

Bio-Rad Laboratories, Inc.$365.08 PEN

-1.79-0.56%

Penumbra, Inc.$317.78 SYK

-5.38-1.95%

Stryker Corporation$270.01 GKOS

-9.41-5.23%

Glaukos Corporation$170.38 ITGR

0.19+0.15%

Integer Holdings Corporation$126.05 ABT

-1.86-1.77%

Abbott Laboratories$103.37 HAE

-2.1-2.04%

Haemonetics Corporation$101.06 MDT

-0.27-0.29%

Medtronic plc$91.62 EW

0.59+0.68%

Edwards Lifesciences Corporation$86.77

Frequently Asked Questions

What is the current Zimmer Biomet Holdings, Inc. (ZBH) stock price?

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stock price is $92.44 in the last trading session. During the trading session, ZBH stock reached the peak price of $93.73 while $91.45 was the lowest point it dropped to. The percentage change in ZBH stock occurred in the recent session was -2.29% while the dollar amount for the price change in ZBH stock was - $2.17.

ZBH's industry and sector of operation?

The NYSE listed ZBH is part of Medical - Devices industry that operates in the broader Healthcare sector. Zimmer Biomet Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ZBH?

Dr. Nitin Goyal M.D.
Chief Science, Technology & Innovation Officer
Mr. Sang Yi
Pres of Asia Pacific
Mr. Bryan C. Hanson
Chairman, Pres & Chief Executive Officer
Mr. Suketu P. Upadhyay
Executive Vice President & Chief Financial Officer
Mr. Chad F. Phipps
Senior Vice President, Gen. Counsel & Sec.
Mr. Paul A. Stellato
Vice President, Controller & Chief Accounting Officer
Mr. Wilfred van Zuilen
Pres of Europe, Middle East & Africa
Ms. Angela Main
Senior Vice President, Global Chief Compliance Officer & Associate Gen. Counsel of Asia Pacific
Mr. Ivan Tornos
Chief Operating Officer
Ms. Keri P. Mattox
SVice President and Chief Communications & Admin. Officer
Mr. Zeeshan Tariq
Senior Vice President & Chief Information Officer

How ZBH did perform over past 52-week?

ZBH's closing price is 16.84% higher than its 52-week low of $79.12 where as its distance from 52-week high of $106.88 is -13.51%.

How many employees does ZBH have?

Number of ZBH employees currently stands at 17,000.

Link for ZBH official website?

Official Website of ZBH is: https://www.zimmerbiomet.com

How do I contact ZBH?

ZBH could be contacted at phone 574 267 6131 and can also be accessed through its website. ZBH operates from 345 East Main Street, Warsaw, IN 46580, United States.

How many shares of ZBH are traded daily?

ZBH stock volume for the day was 1.36M shares. The average number of ZBH shares traded daily for last 3 months was 2.21M.

What is the market cap of ZBH currently?

The market value of ZBH currently stands at $17.88B with its latest stock price at $92.44 and 193.46M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	17000
Beta	0.46
Sales or Revenue	$7.39B
5Y Sales Change%	-0.091%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

Employees	17000
Beta	0.46
Sales or Revenue	$7.39B
5Y Sales Change%	-0.091%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

ZBH Company Profile and Key Details

Zimmer Biomet

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Valuation Metrics

Price Forecast & Outlook

Key Takeaways